[A combination of alupent and adumbran (Tranquo-alupent) for the treatment of the asthmatic syndrome. Single dose studies with pulmonary function tests in double blind technic].
D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000494:pharmacology; D008875:Middle Aged; D010627:Phenethylamines / Q000008:administration & dosage*; D011674:Pulse / Q000187:drug effects; D012118:Resorcinols / Q000008:administration & dosage* / Q000494:pharmacology; D012129:Respiratory Function Tests; D013607:Tablets; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000494:pharmacology
D000336:Aerosols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D013607:Tablets; D014149:Tranquilizing Agents; D009921:Metaproterenol
Ein Kombination von Alupent und Adumbran (Tranquo-Alupent) zur Therapie des asthmatischen Syndroms. Einzeldoisstudien mit Lungenfunktionsprüfungen in Doppeltblindtechnik.